Latest information on COVID-19
Support teaching, research, and patient care.
James Chen is a clinical fellow in Oncology at Stanford. He graduated summa cum laude in Microbiology, Immunology, and Molecular Genetics from UCLA. He trained as an undergraduate in Hong Wu's Lab, where he studied PTEN’s role in T acute lymphoblastic leukemia. From there, he joined the medical scientist training program at Stanford University where he joined the Weissman lab to pursue his research interests in hematopoietic stem cells and bone marrow transplant. After completing his medical and graduate degrees, James joined Forty Seven Inc., a biotechnology startup, as part of a team to bring novel immunotherapy agents through multiple phases of pre-clinical and clinical development for application in malignancies and hematopoietic stem cell transplantation. To further pursue his goal of translating basic research into clinical practice, he completed his internal medicine residency program at Massachusetts General Hospital. As a fellow, James aims to continue bridging the basic, translation, and clinical research spaces, especially in support of early-phase first-in-human studies.